Vnitr Lek 2005, 51(6):690-698

The REAL/WHO classification of neoplastic disease of the lymphoid tissues: 10 years of common language function from the clinical practice view point

T. Papajík*, L. Raida, K. Indrák
Hemato-onkologická klinika Lékařské fakulty UP a FN, Olomouc, přednosta prof. MUDr. Karel Indrák, DrSc.

Neoplasms of lymphoid tissues represent relatively great and heterogeneous group of human tumors. The expansion of data on lymphomagenesis could help us to understand similarities and also differences among various subgroups of malignant lymphomas. Hence there has been an increasing need to exactly define, differentiate and classify individual lymphoma entities. Previous classification systems were based on a neoplastic cell and tissue morphology, only a few information about physiology and pathophysiology of immune system were incorporated in them. These lymphoma classifications have been a source of confusion for many years for both clinicians and pathologists. The construction of a new lymphoma classification was started in early 90th years of 20th century. The classification was publicated in 1994 as "A Revisited European-American Classification of Lymphoid Neoplasms". For the first time in a history it has worked consistently with morphologic, immunophenotypic, genetic and clinical information together. The philosophy and form of REAL classification have been adopted by the new WHO Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues. This scheme is now accepted as a modern and universal language of communication on the field of hemato-oncology.

Keywords: cytogenetics; immunophenotype; lymphoid neoplasms; non-Hodgkin's lymphomas; REAL classification; WHO classification

Received: July 12, 2004; Accepted: October 26, 2004; Published: June 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Papajík T, Raida L, Indrák K. The REAL/WHO classification of neoplastic disease of the lymphoid tissues: 10 years of common language function from the clinical practice view point. Vnitr Lek. 2005;51(6):690-698.
Download citation

References

  1. Aisenberg AC. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 2656-2675. Go to original source... Go to PubMed...
  2. Aisenberg AC. Historical review of lymphomas. Br J Haematol 2000; 109: 466-476. Go to original source... Go to PubMed...
  3. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol 1998; 16: 2780-2795. Go to original source... Go to PubMed...
  4. Armitage JO for the non-Hodgkin's lymphoma classification project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
  5. DeVita VT, Canellos GP. The lymphomas. Sem Hematol 1999; 36: 84-94. Go to PubMed...
  6. DeVita VT, Canellos GP, Chabner B et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1975; 1: 249-250. Go to original source... Go to PubMed...
  7. Harris NL. Revised European - American and World Health Organization classification of non-Hodgkin's lymphomas. In: Mauch PM, Armitage JO, Coiffier B et al. non-Hodgkin's Lymphomas. Philadelphia: Lippincott Williams and Wilkins 2004.
  8. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849. Go to original source... Go to PubMed...
  9. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee Meeting - Airlie House, Virginia, November 1997. Ann Oncol 1999; 10: 1419-1432. Go to original source... Go to PubMed...
  10. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues: report of the clinical advisory committee Meeting, Airlie House, Virginia, November 1997. Histopatology 2000; 36: 69-86. Go to original source... Go to PubMed...
  11. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392. Go to original source...
  12. Hiddemann W, Longo DL, Coiffier B et al. Lymphoma classification - the gap between biology and clinical management is closing. Blood 1996; 88: 4085-4089. Go to original source...
  13. Higby DJ. A practical classification of lymphomas. N Engl J Med 1979; 300: 1283. Go to original source...
  14. Hodgkin T. On some morbid appearances of absorbant glands and spleen. Medico - Chirurgical Transactions 1832; 17: 68-114. Go to original source... Go to PubMed...
  15. Isaacson PG. The current status of lymphoma classification. Br J Haematol 2000; 109: 258-266. Go to original source... Go to PubMed...
  16. Jaffe ES, Harris NL, Stein H et al. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. In: Kleihues P, Sobin L (eds). World Health Organization classification of tumors, Vol. 3. Lyon: IARC Press 2001.
  17. Koeppen H, Vardiman JW. New entities, issues, and controversies in the classification of malignant lymphoma. Semin Oncol 1998; 25: 421-434.
  18. Lennert K, Mohri N, Stein H. The histopathology of malignant lymphoma. Br J Haematol 1975; 31 (Suppl): 193-203. Go to original source...
  19. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488-1503. Go to original source...
  20. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. The non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
  21. Pileri SA, Milani M, Fraternali-Orcioni G et al. From the R.E.A.L. classification to the upcoming WHO scheme: A step toward universal categorization of lymphoma entities? Ann Oncol 1998; 9: 607-612. Go to original source... Go to PubMed...
  22. Prausová D, Krejsek J, Žák P et al. Význam imunofenotypového vyšetření v diagnostice B-lymfoproliferativních onemocnění. Vnitř Lék 2004; 50(1): 45-53. Go to PubMed...
  23. Rosenberg SA. Classification of lymphoid Neoplasms. Blood 1994; 84: 1359-1360. Go to original source...
  24. Shipp M, Harrington D. A predictive model for aggressive non-Hodgkin's lymphoma: The International NHL Prognostic Factors Project. N Engl J Med. 1993; 329: 987-994. Go to original source... Go to PubMed...
  25. Trümper LH, Brittinger G, Diehl V et al. non-Hodgkin's lymphoma: A history of classifications and clinical observations. In: Mauch PM, Armitage JO, Coiffier B et al. non-Hodgkin's Lymphomas. Philadelphia: Lippincott Williams and Wilkins 2004.
  26. Wilks S. Cases of enlargement of the lymphatic glands and spleen (or, Hodgkin disease). With remarks. Guy's Hosp Rep 1865; 11: 56-67.
  27. Willis RA. Tumours of lymphoid tissue. In: Willis RA (ed). Pathology of tumours. St. Louis: Mosby 1948.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.